Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07347002

Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

Sponsor: Valneva Austria GmbH

View on ClinicalTrials.gov

Summary

This is an observational, non-interventional, test-negative case-control (TNCC) study to estimate the vaccine effectiveness of VLA1553 against Chikungunya virus in a real-world setting.

Official title: A Test-Negative Case-control Study to Evaluate the Effectiveness of VLA1553 Against Chikungunya Virus Disease During a Pilot Vaccination Strategy in Brazil

Key Details

Gender

All

Age Range

18 Years - 59 Years

Study Type

OBSERVATIONAL

Enrollment

1200

Start Date

2026-02-02

Completion Date

2027-12-31

Last Updated

2026-02-11

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Live-attenuated CHIKV vaccine VLA1553

Non-interventional study: VLA1553 is used in the pilot vaccination strategy which is linked to this observational study.

Locations (4)

Universidade Federal Do Ceará

Fortaleza, Ceará, Brazil

Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras

Belo Horizonte, Minas Gerais, Brazil

Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus

Laranjeiras, Sergipe, Brazil

Fundação Faculdade Regional De Medicina De São José Do Rio Preto

São Pedro, São Paulo, Brazil